
Loading, please wait...

Loading, please wait...

Understanding the HSP90 conformational transition is a major milestone in molecular biology and oncology research. Scientists recently utilized explainable machine learning (ML) to explore how this protein moves on a millisecond timescale. Specifically, the research team focused on the ATP-lid transition within the Heat Shock Protein 90 (HSP90), which acts as a critical molecular chaperone. Their simulations yielded relative free energies that align perfectly with nuclear magnetic resonance (NMR) data, providing a high level of confidence in the results.
Researchers employed explainable machine-learning-based collective variables (CVs) to map the protein's free-energy landscape efficiently. This surrogate model allowed for the identification of key residues that drive the transition process. Consequently, the study offers a detailed mechanistic view at atomistic resolution. The ML-CV model also demonstrated impressive transferability to mutant variants. It successfully reproduced experimental population shifts, showing its utility across different biological contexts.
Furthermore, the integrated sampling strategy provides precise kinetic rates for these complex transitions. By combining biased enhanced sampling with unbiased weighted ensemble algorithms, the team overcame traditional computational limitations. These findings will likely accelerate the development of more effective and selective HSP90 inhibitors. Thus, the integration of ML and molecular dynamics represents a significant leap forward for future drug design efforts in India and globally.
HSP90 is a molecular chaperone that helps fold oncoproteins essential for tumor growth and survival. Inhibiting this protein leads to the degradation of these oncoproteins, making it a powerful therapeutic strategy.
Explainable ML identifies specific amino acid residues responsible for protein movement. This provides "interpretable" data that traditional simulations often struggle to clarify at such a high resolution.
The ATP-lid transition is a conformational shift in the N-terminal domain of HSP90. This movement is necessary for ATP binding and hydrolysis, which powers the chaperone's activity.
Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or a substitute for professional healthcare. Refer to the latest local and national guidelines for clinical practice.
References
Chatterjee S et al. Explainable Machine Learning Guided Enhanced Sampling of Protein Conformational Transition in HSP90. J Chem Theory Comput. 2026 Apr 17. doi: 10.1021/acs.jctc.6c00132. PMID: 41994866.
Goel B, Jaiswal S, Tripathi N. Recent advances in HSP90 inhibitors as targeted cancer therapy: Chemical scaffolds, isoform selectivity, and clinical progress. Bioorg Chem. 2025 Aug;163:108782.
Kumar A, et al. Recent progress in the development of HSP90 inhibitors: structure-activity relationship and biological evaluation studies. Mol Divers. 2025 Aug 6. doi: 10.1007/s11030-025-11314-3.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study utilizes explainable ML to map the HSP90 protein's ATP-lid transition, offering new mechanistic insights for targeted inhibitor design in oncology....
6 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today